Literature DB >> 29592893

Recurrent STAT3-JAK2 fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract.

Ayush Sharma1, Naoki Oishi2,3, Rebecca L Boddicker2, Guangzhen Hu2, Hailey K Benson2, Rhett P Ketterling2, Patricia T Greipp2, Darlene L Knutson2, Sara M Kloft-Nelson2, Rong He2, Bruce W Eckloff4, Jin Jen2, Asha A Nair5, Jaime I Davila5, Surendra Dasari5, Konstantinos N Lazaridis1,6, N Nora Bennani7, Tsung-Teh Wu2, Grzegorz S Nowakowski6,7, Joseph A Murray1, Andrew L Feldman2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29592893      PMCID： PMC5958657          DOI： 10.1182/blood-2018-01-830968

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   25.476


× No keyword cloud information.
  22 in total

1.  Somatic STAT3 mutations in large granular lymphocytic leukemia.

Authors:  Hanna L M Koskela; Samuli Eldfors; Pekka Ellonen; Arjan J van Adrichem; Heikki Kuusanmäki; Emma I Andersson; Sonja Lagström; Michael J Clemente; Thomas Olson; Sari E Jalkanen; Muntasir Mamun Majumder; Henrikki Almusa; Henrik Edgren; Maija Lepistö; Pirkko Mattila; Kathryn Guinta; Pirjo Koistinen; Taru Kuittinen; Kati Penttinen; Alun Parsons; Jonathan Knowles; Janna Saarela; Krister Wennerberg; Olli Kallioniemi; Kimmo Porkka; Thomas P Loughran; Caroline A Heckman; Jaroslaw P Maciejewski; Satu Mustjoki
Journal:  N Engl J Med       Date:  2012-05-17       Impact factor: 91.245

Review 2.  The saga of JAK2 mutations and translocations in hematologic disorders: pathogenesis, diagnostic and therapeutic prospects, and revised World Health Organization diagnostic criteria for myeloproliferative neoplasms.

Authors:  Cristina A Smith; Guang Fan
Journal:  Hum Pathol       Date:  2008-06       Impact factor: 3.466

3.  Ruxolitinib inhibits transforming JAK2 fusion proteins in vitro and induces complete cytogenetic remission in t(8;9)(p22;p24)/PCM1-JAK2-positive chronic eosinophilic leukemia.

Authors:  Els Lierman; Dominik Selleslag; Sanne Smits; Johan Billiet; Peter Vandenberghe
Journal:  Blood       Date:  2012-08-16       Impact factor: 22.113

4.  Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene.

Authors:  Elisa Rumi; Jelena D Milosevic; Dominik Selleslag; Ilaria Casetti; Els Lierman; Daniela Pietra; Chiara Cavalloni; Marta Bellini; Chiara Milanesi; Irene Dambruoso; Cesare Astori; Robert Kralovics; Peter Vandenberghe; Mario Cazzola
Journal:  Ann Hematol       Date:  2015-07-23       Impact factor: 3.673

5.  Efficacy of ruxolitinib in chronic eosinophilic leukemia associated with a PCM1-JAK2 fusion gene.

Authors:  Elisa Rumi; Jelena D Milosevic; Ilaria Casetti; Irene Dambruoso; Daniela Pietra; Emanuela Boveri; Marina Boni; Paolo Bernasconi; Francesco Passamonti; Robert Kralovics; Mario Cazzola
Journal:  J Clin Oncol       Date:  2013-04-29       Impact factor: 44.544

6.  Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells.

Authors:  Can Küçük; Bei Jiang; Xiaozhou Hu; Wenyan Zhang; John K C Chan; Wenming Xiao; Nathan Lack; Can Alkan; John C Williams; Kendra N Avery; Pınar Kavak; Anna Scuto; Emel Sen; Philippe Gaulard; Lou Staudt; Javeed Iqbal; Weiwei Zhang; Adam Cornish; Qiang Gong; Qunpei Yang; Hong Sun; Francesco d'Amore; Sirpa Leppä; Weiping Liu; Kai Fu; Laurence de Leval; Timothy McKeithan; Wing C Chan
Journal:  Nat Commun       Date:  2015-01-14       Impact factor: 14.919

Review 7.  Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases.

Authors:  Robert Roskoski
Journal:  Pharmacol Res       Date:  2016-07-26       Impact factor: 7.658

8.  Indolent T-cell lymphoproliferative disease of the gastrointestinal tract.

Authors:  Anamarija M Perry; Roger A Warnke; Qinglong Hu; Philippe Gaulard; Christiane Copie-Bergman; Serhan Alkan; Huan-You Wang; Jason X Cheng; Chris M Bacon; Jan Delabie; Erik Ranheim; Can Kucuk; Xiaozhou Hu; Dennis D Weisenburger; Elaine S Jaffe; Wing C Chan
Journal:  Blood       Date:  2013-09-05       Impact factor: 22.113

9.  The role of the N-terminal domain in dimerization and nucleocytoplasmic shuttling of latent STAT3.

Authors:  Michael Vogt; Tamas Domoszlai; Dzina Kleshchanok; Swen Lehmann; Anne Schmitt; Valeria Poli; Walter Richtering; Gerhard Müller-Newen
Journal:  J Cell Sci       Date:  2011-02-15       Impact factor: 5.285

10.  Indolent small intestinal CD4+ T-cell lymphoma is a distinct entity with unique biologic and clinical features.

Authors:  Elizabeth Margolskee; Vaidehi Jobanputra; Suzanne K Lewis; Bachir Alobeid; Peter H R Green; Govind Bhagat
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240
View more
  19 in total

Review 1.  Update on the classification of T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms.

Authors:  Akira Satou; N Nora Bennani; Andrew L Feldman
Journal:  Expert Rev Hematol       Date:  2019-07-31       Impact factor: 2.929

2.  T-cell and NK-cell neoplasms of the gastrointestinal tract - recurrent themes, but clinical and biological distinctions exist.

Authors:  Elaine S Jaffe
Journal:  Haematologica       Date:  2020-07       Impact factor: 9.941

3.  Recurrent somatic JAK3 mutations in NK-cell enteropathy.

Authors:  Wenbin Xiao; Gaurav K Gupta; Jinjuan Yao; Yoon J Jang; Liqiang Xi; Jeeyeon Baik; Allison Sigler; Anita Kumar; Alison J Moskowitz; Maria E Arcila; Mark Raffeld; Stefania Pittaluga; Ahmet Dogan; Elaine S Jaffe
Journal:  Blood       Date:  2019-08-05       Impact factor: 22.113

4.  Disease Progression in a Patient With Indolent T-Cell Lymphoproliferative Disease of the Gastrointestinal Tract.

Authors:  Anamarija M Perry; Nathanael G Bailey; Michelle Bonnett; Elaine S Jaffe; Wing C Chan
Journal:  Int J Surg Pathol       Date:  2018-07-09       Impact factor: 1.271

5.  Transcriptional Regulation of Voltage-Gated Sodium Channels Contributes to GM-CSF-Induced Pain.

Authors:  Fan Zhang; Yiying Wang; Yu Liu; Hao Han; Dandan Zhang; Xizhenzi Fan; Xiaona Du; Nikita Gamper; Hailin Zhang
Journal:  J Neurosci       Date:  2019-04-23       Impact factor: 6.167

Review 6.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.

Authors:  Rita Alaggio; Catalina Amador; Ioannis Anagnostopoulos; Ayoma D Attygalle; Iguaracyra Barreto de Oliveira Araujo; Emilio Berti; Govind Bhagat; Anita Maria Borges; Daniel Boyer; Mariarita Calaminici; Amy Chadburn; John K C Chan; Wah Cheuk; Wee-Joo Chng; John K Choi; Shih-Sung Chuang; Sarah E Coupland; Magdalena Czader; Sandeep S Dave; Daphne de Jong; Ming-Qing Du; Kojo S Elenitoba-Johnson; Judith Ferry; Julia Geyer; Dita Gratzinger; Joan Guitart; Sumeet Gujral; Marian Harris; Christine J Harrison; Sylvia Hartmann; Andreas Hochhaus; Patty M Jansen; Kennosuke Karube; Werner Kempf; Joseph Khoury; Hiroshi Kimura; Wolfram Klapper; Alexandra E Kovach; Shaji Kumar; Alexander J Lazar; Stefano Lazzi; Lorenzo Leoncini; Nelson Leung; Vasiliki Leventaki; Xiao-Qiu Li; Megan S Lim; Wei-Ping Liu; Abner Louissaint; Andrea Marcogliese; L Jeffrey Medeiros; Michael Michal; Roberto N Miranda; Christina Mitteldorf; Santiago Montes-Moreno; William Morice; Valentina Nardi; Kikkeri N Naresh; Yasodha Natkunam; Siok-Bian Ng; Ilske Oschlies; German Ott; Marie Parrens; Melissa Pulitzer; S Vincent Rajkumar; Andrew C Rawstron; Karen Rech; Andreas Rosenwald; Jonathan Said; Clémentine Sarkozy; Shahin Sayed; Caner Saygin; Anna Schuh; William Sewell; Reiner Siebert; Aliyah R Sohani; Reuben Tooze; Alexandra Traverse-Glehen; Francisco Vega; Beatrice Vergier; Ashutosh D Wechalekar; Brent Wood; Luc Xerri; Wenbin Xiao
Journal:  Leukemia       Date:  2022-06-22       Impact factor: 12.883

7.  Primary cytotoxic T-cell lymphomas harbor recurrent targetable alterations in the JAK-STAT pathway.

Authors:  Katie Lee; Mark G Evans; Lei Yang; Spencer Ng; Caroline Snowden; Michael Khodadoust; Ryanne A Brown; Nicholas A Trum; Christiane Querfeld; Linda T Doan; Jinming Song; Hailing Zhang; Alejandro A Gru; Gary S Wood; David A Wada; Vignesh Shanmugam; Paul L Haun; Jon C Aster; Lyn M Duncan; Joan Guitart; David M Weinstock; Valentina Nardi; Jaehyuk Choi
Journal:  Blood       Date:  2021-12-09       Impact factor: 25.476

Review 8.  Peripheral T-cell lymphoma - are we making progress?

Authors:  Niloufer Khan; Neval Ozkaya; Alison Moskowitz; Ahmet Dogan; Steven Horwitz
Journal:  Best Pract Res Clin Haematol       Date:  2018-07-17       Impact factor: 3.020

9.  Next generation sequencing of breast implant-associated anaplastic large cell lymphomas reveals a novel STAT3-JAK2 fusion among other activating genetic alterations within the JAK-STAT pathway.

Authors:  Andrés E Quesada; Yanming Zhang; Ryan Ptashkin; Caleb Ho; Steven Horwitz; Ryma Benayed; Ahmet Dogan; Maria E Arcila
Journal:  Breast J       Date:  2021-02-18       Impact factor: 2.431

Review 10.  Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up.

Authors:  Francisco Vega; Catalina Amador; Amy Chadburn; Eric D Hsi; Graham Slack; L Jeffrey Medeiros; Andrew L Feldman
Journal:  Mod Pathol       Date:  2021-09-28       Impact factor: 7.842
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.